Advertisement Stirling names new chief financial officer - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Stirling names new chief financial officer

Healthcare group, Stirling Products (Stirling), a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products, has named Michael Kean as its new chief financial officer.

Prior to joining Stirling, Kean has held positions as a tutor at the University of Technology in Sydney and as a senior researcher in fields including the Financial Reporting of Intangible Assets, Executive Remuneration, Voluntary Disclosure and Australian R & D.

Stirling said that Kean has commenced a review of the company’s operations and has already introduced a number of cost-cutting initiatives across all operations with overall financing and management accounting in process of being better positioned to accommodate the company’s forecast growth, sales and needs.